Elekta (OTCMKTS:EKTAY) Shares Gap Up – Time to Buy?

Elekta AB (OTCMKTS:EKTAY) shares gapped up prior to trading on Thursday . The stock had previously closed at $5.75, but opened at $6.00. Elekta shares last traded at $6.00, with a volume of 226 shares changing hands.

Wall Street Analysts Forecast Growth

EKTAY has been the subject of several research analyst reports. UBS Group began coverage on Elekta in a research note on Wednesday, September 3rd. They set a “sell” rating for the company. Zacks Research upgraded shares of Elekta from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 16th. Three analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Reduce”.

Elekta Stock Down 1.3%

The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.82 and a current ratio of 1.05. The firm has a market capitalization of $2.18 billion, a P/E ratio of 84.60 and a beta of 1.04. The stock has a fifty day moving average price of $5.15 and a two-hundred day moving average price of $5.07.

Elekta (OTCMKTS:EKTAY) last announced its quarterly earnings data on Wednesday, November 26th. The company reported $0.07 earnings per share (EPS) for the quarter. The firm had revenue of $427.85 million for the quarter, compared to analysts’ expectations of $436.91 million. Elekta had a return on equity of 12.06% and a net margin of 1.62%. Research analysts forecast that Elekta AB will post 0.36 EPS for the current year.

Elekta Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.